A Chairman is sought for a startup that‘s developing and applying innovative computational approaches to genomics for drug target discovery and precision medicine.

Outsee is well-versed in a variety of genomics, AI and cohort analysis techniques. They are also bioinformatics generalists and work with just about any technology encountered in biological research. They have individual past track records of inventing and developing many world-leading bioinformatics tools and resources in academia.

Outsee has a fundamental value proposition for organisations that have exhausted standard approaches to analysing their genetic cohorts and looking to use genomics for discovery of causal mechanisms. Outsee is also using investment to pursue the development of internal assets in parallel with co-development with Pharma partners. Outsee’s proprietary AI technology Nomaly [Lu et al. 2023 Nature Comms] will produce results not available from any other method, generating additional value from any cohort.

The world of genomics analysis holds great promise, but much of the value in our genome remains untapped. That’s why Outsee’s goal is to increase the value that can be gained from existing genome resources. No matter how small or how large the dataset, they offer the potential for novel discovery.

Outsee seeks a chairman with extensive experience in developing small life science businesses and a track record of successful fundraising for drug development. Significant networks in this area, both within the UK and internationally would be advantageous. The ideal candidate will provide scrutiny, leadership, oversight, and strategic input to the Company and support to the experienced CEO and Senior Management Team. The Chair will ensure an effective relationship between all Board Members and Stakeholders/Shareholders and act as an independent voice in the event of a dispute between the directors. The Company currently has limited funds to be able to remunerate the Chair role, but this will change when the next milestones are met. Board meetings are bi-monthly. The time commitment is around 1 day per month.